Synchronous Malignancies Identified by 18F-fluciclovine Positron Emission Tomography for Prostate Cancer: Case Series and Mini-Review
Tài liệu tham khảo
Parent, 2018, Update on (18)F-fluciclovine PET for prostate cancer imaging, J Nucl Med, 59, 733, 10.2967/jnumed.117.204032
Ono, 2015, [(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells, Nucl Med Biol, 42, 887, 10.1016/j.nucmedbio.2015.07.005
Bach-Gansmo, 2017, Multisite experience of the safety, detection rate and diagnostic performance of fluciclovine ((18)F) positron emission tomography/computerized tomography imaging in the staging of biochemically recurrent prostate cancer, J Urol, 197, 676
Shoup, 1999, Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors, J Nucl Med, 40, 331
Jethanandani, 2019, Incidental detection of oropharyngeal cancer with fluciclovine PET, Head Neck, 41, E141, 10.1002/hed.25798
Galgano, 2019, Patient demographics and referral patterns for [F-18]fluciclovine-PET imaging at a tertiary academic medical center, J Am Coll Radiol, 16, 315, 10.1016/j.jacr.2018.09.026
Okudaira, 2011, Putative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer, J Nucl Med, 52, 822, 10.2967/jnumed.110.086074
Oka, 2012, Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cells, Nucl Med Biol, 39, 109, 10.1016/j.nucmedbio.2011.06.008
Bhanvadia, 2019, Incidental detection of metastatic penile squamous-cell carcinoma with anti-1-amino-3-F-18-fluorocyclobutane-1-carboxylic acid ((18)F-fluciclovine) PET/CT in a patient with recurrent prostate cancer, Clin Genitourin Cancer, 17, e184, 10.1016/j.clgc.2018.10.014
Raghavan, 2019, Incidentally detected oropharyngeal squamous cell carcinoma on 18F-fluciclovine PET/CT, Clin Nucl Med, 44, e367, 10.1097/RLU.0000000000002507
Teoh, 2017, Recurrent malignant melanoma detected on 18F-fluciclovine PET/CT imaging for prostate cancer, Clin Nucl Med, 42, 803, 10.1097/RLU.0000000000001789
Bitar, 2020, Incidental 18F-fluciclovine uptake in a Warthin tumor of the parotid gland in a patient undergoing PET/CT imaging for biochemical recurrent prostate cancer, Clin Nucl Med, 45, e208, 10.1097/RLU.0000000000002938
Boatright, 2020, Incidental dedifferentiated mediastinal liposarcoma on F-18-fluciclovine PET/CT, Clin Imaging, 59, 21, 10.1016/j.clinimag.2019.08.004
Nguyen, 2018, Fluciclovine, anti-1-amino-3-[(18)F]-fluorocyclobutane-1-carboxylic acid: a novel radiotracer for meningioma, World Neurosurg, 119, 132, 10.1016/j.wneu.2018.07.231
Manganaro, 2019, Multifocal meningiomas mimicking dural-based intracranial metastases at 18F-fluciclovine PET/CT, Clin Nucl Med, 44, 594, 10.1097/RLU.0000000000002629
Balážová, 2020, Incidental accumulation of fluciclovine in neuroendocrine tumour in a patient with oncological duplicity, Case Rep Oncol, 13, 431, 10.1159/000506829
Wang, 2020, Pituitary adenoma on 18F-fluciclovine PET/CT, Clin Nucl Med, 45, e65, 10.1097/RLU.0000000000002777
Nguyen, 2020, Differential 18F-FDG and 18F-fluciclovine uptake pattern in a patient with poorly differentiated adenocarcinoma of the lung and prostate cancer biochemical recurrence, Clin Nucl Med, 45, e63, 10.1097/RLU.0000000000002781
Sannananja, 2018, 18F-fluciclovine uptake by an incidentally detected hepatocellular carcinoma in a case of biochemically recurrent prostate cancer, Clin Nucl Med, 43, 695, 10.1097/RLU.0000000000002176
Gill, 2018, Metastatic male breast cancer with increased uptake on 18F-fluciclovine PET/CT scan, Clin Nucl Med, 43, 23, 10.1097/RLU.0000000000001893
Winter
Akin-Akintayo, 2019, Uptake of 18F-fluciclovine in Paget disease, Clin Nucl Med, 44, e614, 10.1097/RLU.0000000000002670
Wo, 2019, 18F-fluciclovine uptake in celiac ganglia: a pitfall in prostate cancer PET imaging, Clin Nucl Med, 44, 743, 10.1097/RLU.0000000000002693
Oldan, 2019, Trapping of 18F-fluciclovine (FACBC) in superior sagittal sinus, Clin Nucl Med, 44, 48, 10.1097/RLU.0000000000002352